The CGTLive™ Neurology specialty topic page houses video interviews with key opinion leaders in the field of neurology about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings related to cell therapies, gene therapies, and engineered and regenerative medicines developed for neurologic disorders and diseases. It also contains up-to-date clinical news coverage in the field of gene and cell therapy for central nervous system disorders.
April 25th 2024
The company expects to open the first clinical site in the DOSED study in the second quarter of 2024.
Sukumar Nagendran, MD, on the Potential of TSHA-102 in Pediatric Patients With Rett Syndrome
January 21st 2024The president and head of R&D at Taysha Gene Therapies discussed his expectation that younger patients my see even better results with the company’s gene therapy than the adult patients treated so far.